CTRI/2024/04/066155Not yet recruitingPhase 4
A comparative study on efficacy of intralesional methotrexate vs intralesional triamcinolone acetonide in chronic plaque psoriasis - NI
Sampath V0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1)All patients with clinical features of chronic Plaque psoriasis with less than 5 Plaques
- •2)Patients who have given consent for the study and are willing to come for regular follow up at the psoriasis clinic.
- •3)Patients who had not been on any systemic and topical anti psoriatic medications for at least the past 2 months will be enrolled.
Exclusion Criteria
- •1)Patients with unstable psoriasis
- •2)Pregnant and Lactating Women
- •3)Patients of Psoriasis vulgaris with history of Hypersensitivity to MTX or Triamcinolone.
- •4)Patients with bleeding disorders and on anti-coagulant therapy.
Investigators
Similar Trials
Not yet recruiting
Phase 1
Comparison of the effectiveness of Intralesional Methotrexate with Intralesional Triamcinolone Acetonide in the treatment of Localized patchy hair loss of the scalp.CTRI/2024/08/072542Karthiyaini A
Not yet recruiting
Phase 2
To Compare Acyclovir and 5-Flurouracil in the treatment of WartsCTRI/2023/07/055225Akepati Samhitha
Not yet recruiting
Not Applicable
comparison of acyclovir and bleomycin injection in treatment of wartsCTRI/2022/07/044451Military hospital
Completed
Not Applicable
To compare efficacy of treatment by intralesional bleomycin and intralesional vitamin D-3 in common warts.CTRI/2021/04/032610Department of Dermatology Venereology and Leprosy32
Recruiting
Phase 3
Comparison of the therapeutic effect of intralesional injection of botulinum toxin with placebo in patients with androgenetic alopecia receiving finasteride tabmale androgenetic alopecia.Androgenic alopeciaIRCT20191013045092N3Shiraz University of Medical Sciences48
